Renal Function and All-Cause Mortality Risk Among Cancer Patients

被引:42
作者
Yang, Yan [1 ]
Li, Hui-yan [1 ]
Zhou, Qian [1 ]
Peng, Zhen-wei [2 ]
An, Xin [3 ]
Li, Wei [1 ]
Xiong, Li-ping [1 ]
Yu, Xue-qing [1 ]
Jiang, Wen-qi [3 ]
Mao, Hai-ping [1 ]
机构
[1] Sun Yat Sen Univ, Key Lab Nephrol, Minist Hlth China,Dept Nephrol, Guangdong Prov Key Lab Nephrol,Affiliated Hosp 1, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Dept Oncol, 651 Dongfeng Rd, Guangzhou 510080, Guangdong, Peoples R China
关键词
CHRONIC KIDNEY-DISEASE; COLORECTAL-CANCER; SURGICAL RESECTION; LUNG-CANCER; COMORBIDITY; INSUFFICIENCY; THERAPY; IMPACT; AGE; IMPAIRMENT;
D O I
10.1097/MD.0000000000003728
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Renal dysfunction predicts all-cause mortality in general population. However, the prevalence of renal insufficiency and its relationship with mortality in cancer patients are unclear. We retrospectively studied 9465 patients with newly diagnosed cancer from January 2010 to December 2010. Renal insufficiency was defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m(2) using the Chronic Kidney Disease Epidemiology Collaboration equation. The hazard ratio (HR) of all-cause mortality associated with baseline eGFR was assessed by Cox regression. Three thousand sixty-nine patients (32.4%) exhibited eGFR < 90 mL/min/1.73 m(2) and 3% had abnormal serum creatinine levels at the time of diagnosis. Over a median follow-up of 40.5 months, 2705 patients (28.6%) died. Compared with the reference group (eGFR >= 60 mL/min/1.73 m 2), an elevated all-cause mortality was observed among patients with eGFR< 60 mL/min/1.73 m(2) stratified by cancer stage in the entire cohort, the corresponding hazard ratios were 1.87 (95% CI, 1.41-2.47) and 1.28 (95% CI, 1.01-1.62) for stage I to III and stage IV, respectively. However, this relationship was not observed after multivariate adjustment. Subgroup analysis found that eGFR< 60 mL/min/1.73m 2 independently predicted death among patients with hematologic (adjusted HR 2.93, 95% CI [1.36-6.31]) and gynecological cancer (adjusted HR 2.82, 95% CI [1.19-6.70]), but not in those with other cancer. Five hundred fifty-seven patients (6%) had proteinuria. When controlled for potential confounding factors, proteinuria was a risk factor for all-cause mortality among patients in the entire cohort, regardless of cancer stage and eGFR values. When patients were categorized by specific cancer type, the risk of all-cause death was only significant in patients with digestive system cancer (adjusted HR, 1.85 [1.48-2.32]). The prevalence of renal dysfunction was common in patients with newly diagnosed cancer. Patients with eGFR < 60 mL/min/1.73 m(2) or proteinuria were associated with increased risk for all-cause mortality, this relation depended on cancer site.
引用
收藏
页数:8
相关论文
共 35 条
[1]   Importance of monitoring renal function in patients with cancer [J].
Aapro, Matti ;
Launay-Vacher, Vincent .
CANCER TREATMENT REVIEWS, 2012, 38 (03) :235-240
[2]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[3]   A review of global cancer burden: Trends, challenges, strategies, and a role for surgeons [J].
Are, Chandrakanth ;
Rajaram, Shireen ;
Are, Madhuri ;
Raj, Hemanth ;
Anderson, Benjamin O. ;
Swamy, Ramesh Chaluvarya ;
Vijayakumar, Manavalan ;
Song, Tianqiang ;
Pandey, Manoj ;
Edney, James A. ;
Cazap, Eduardo L. .
JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (02) :221-226
[4]   Age and comorbidity as independent prognostic factors in the treatment of non-small-cell lung cancer: A review of national cancer institute of Canada clinical trials group trials [J].
Asmis, Timothy R. ;
Ding, Keyue ;
Seymour, Lesley ;
Shepherd, Frances A. ;
Leighl, Natasha B. ;
Winton, Tim L. ;
Whitehead, Marlo ;
Spaans, Johanna N. ;
Graham, Barbara C. ;
Goss, Glenwood D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (01) :54-59
[5]   Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation [J].
Choi, Michael ;
Sun, Can-Lan ;
Kurian, Seira ;
Carter, Andrea ;
Francisco, Liton ;
Forman, Stephen J. ;
Bhatia, Smita .
CANCER, 2008, 113 (07) :1580-1587
[6]   Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms [J].
Christensen, Alexander Sidelmann ;
Moller, Jonas Bech ;
Hasselbalch, Hans Carl .
LEUKEMIA RESEARCH, 2014, 38 (04) :490-495
[7]   Overall survival and renal function after partial and radical nephrectomy among older patients with localised renal cell carcinoma: A propensity-matched multicentre study [J].
Chung, Jae Seung ;
Son, Nak Hoon ;
Lee, Sang Eun ;
Hong, Sung Kyu ;
Lee, Sang Chul ;
Kwak, Cheol ;
Hong, Sung Hoo ;
Kim, Yong June ;
Kang, Seok Ho ;
Byun, Seok-Soo .
EUROPEAN JOURNAL OF CANCER, 2015, 51 (04) :489-497
[8]   Impact of chronic kidney disease on postoperative outcome following colorectal cancer surgery [J].
Currie, A. ;
Malietzis, G. ;
Askari, A. ;
Nachiappan, S. ;
Swift, P. ;
Jenkins, J. T. ;
Faiz, O. D. ;
Kennedy, R. H. .
COLORECTAL DISEASE, 2014, 16 (11) :879-885
[9]   Moderate Renal Function Impairment Does Not Affect Outcomes of Reduced-Intensity Conditioning with Fludarabine and Melphalan for Allogeneic Hematopoietic Stem Cell Transplantation [J].
de Souza, Jonas A. ;
Saliba, Rima M. ;
Patah, Poliana ;
Rondon, Gabriela ;
Ribeiro, Rachel ;
Silva, Leandro de Padua ;
Qazilbash, Muzaffar H. ;
Hosing, Chitra ;
Popat, Uday ;
Efebera, Yvonne ;
Champlin, Richard E. ;
de Lima, Marcos .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) :1094-1099
[10]   Is chronic kidney disease an independent risk factor for mortality in breast cancer? [J].
Dubose, Arielle C. ;
Chu, Quyen D. ;
Li, Benjamin D. L. ;
Kim, Roger H. .
JOURNAL OF SURGICAL RESEARCH, 2013, 184 (01) :260-264